Damdamon, Maysarah -.
HRN: 28-64-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2026
CEFUROXIME 1.5GM (VIAL)
04/21/2026
04/23/2026
IVTT
1.5g
Q12h
UTI
Checking Initial Appropriateness